SG38183G - Antitumour agent - Google Patents
Antitumour agentInfo
- Publication number
- SG38183G SG38183G SG381/83A SG38183A SG38183G SG 38183 G SG38183 G SG 38183G SG 381/83 A SG381/83 A SG 381/83A SG 38183 A SG38183 A SG 38183A SG 38183 G SG38183 G SG 38183G
- Authority
- SG
- Singapore
- Prior art keywords
- antitumour agent
- antitumour
- agent
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2133979A JPS55113718A (en) | 1979-02-27 | 1979-02-27 | Antitumor agent |
Publications (1)
Publication Number | Publication Date |
---|---|
SG38183G true SG38183G (en) | 1984-07-20 |
Family
ID=12052351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG381/83A SG38183G (en) | 1979-02-27 | 1983-06-30 | Antitumour agent |
Country Status (12)
Country | Link |
---|---|
US (1) | US4347240A (nl) |
JP (1) | JPS55113718A (nl) |
BR (1) | BR8001129A (nl) |
CA (1) | CA1124176A (nl) |
CH (1) | CH653556A5 (nl) |
DE (1) | DE3007412A1 (nl) |
FR (1) | FR2450108B1 (nl) |
HK (1) | HK23784A (nl) |
IT (1) | IT1129802B (nl) |
MY (1) | MY8500010A (nl) |
NL (1) | NL189999C (nl) |
SG (1) | SG38183G (nl) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3125797A1 (de) * | 1981-06-30 | 1983-01-13 | Rudolf Dr. Schuler | Diaetetisches mittel |
US5965414A (en) | 1985-11-04 | 1999-10-12 | Microlife Technics, Inc. | Process for producing yeast and mold inhibiting products with lactobacillus |
JPH0696538B2 (ja) * | 1985-12-19 | 1994-11-30 | 株式会社アドバンス | 抗発癌剤 |
WO1991005851A1 (en) * | 1989-10-10 | 1991-05-02 | Tartusky Gosudarstvenny Universitet | Bacterium strain lactobacillus casei subsp. casei 37 for production of a bacterial biological preparation |
JPH0755908B2 (ja) * | 1992-11-24 | 1995-06-14 | 財団法人京都パストゥール研究所 | 免疫機能助長剤 |
US5840318A (en) * | 1993-05-11 | 1998-11-24 | Immunom Technologies, Inc. | Methods and compositions for modulating immune systems of animals |
WO1994026114A1 (en) * | 1993-05-11 | 1994-11-24 | Immunom Technologies, Inc. | Method of stimulating and modulating the immune system of animals with microbial compositions |
US7189834B2 (en) * | 1993-05-11 | 2007-03-13 | Marshall William E | Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection |
US6180100B1 (en) * | 1994-09-30 | 2001-01-30 | Urex Biotech., Inc. | Lactobacillus compositions and methods for treating urinary tract infections |
AUPN907296A0 (en) * | 1996-04-02 | 1996-04-26 | Commonwealth Scientific And Industrial Research Organisation | Biocontrol agents for use in treatment of opportunistic infections |
EP0974666A4 (en) | 1996-06-26 | 2004-12-15 | Yakult Honsha Kk | METHODS FOR TRANSFERRING GENES INTO A CHROMOSOME |
DE69842112D1 (de) * | 1997-02-11 | 2011-03-10 | Entpr Ie Trd As Bioresearch Ie | Nd daraus hergestellte antimikrobielle mittel |
US6645506B1 (en) * | 1997-04-18 | 2003-11-11 | Ganeden Biotech, Inc. | Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil |
AU749001B2 (en) * | 1997-04-18 | 2002-06-13 | Ganeden Biotech, Inc. | Topical use of probiotic bacillus spores to prevent or control microbial infections |
ID29150A (id) * | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
PE20030283A1 (es) * | 2001-07-26 | 2003-05-01 | Alimentary Health Ltd | Cepas de lactobacillus casei |
WO2005000222A2 (en) * | 2003-05-30 | 2005-01-06 | Amylin Pharmaceuticals, Inc. | Novel methods and compositions for enhanced transmucosal delivery of peptides and proteins |
US20050112097A1 (en) * | 2003-11-26 | 2005-05-26 | Hinton Golden S. | Method for the treatment of cancer |
CA2597229A1 (en) * | 2005-02-11 | 2006-08-17 | Technologie Biolactis Inc. | Use of lactobacillus kefiranofaciens as a probiotic and a synbiotic |
US8404823B2 (en) * | 2006-10-27 | 2013-03-26 | Kabushiki Kaisha Yakult Honsha | Cytokine production regulator gene and use thereof |
CN101626773B (zh) * | 2006-11-02 | 2013-04-17 | 奥力有限公司 | 一种生体治愈促进剂 |
KR20100008831A (ko) * | 2008-07-17 | 2010-01-27 | 주식회사 쎌바이오텍 | 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물 |
PL2823822T3 (pl) | 2009-11-11 | 2017-09-29 | Alimentary Health Limited | Szczep Bifidobakterium |
AU2010317422A1 (en) | 2009-11-11 | 2012-05-31 | Alimentary Health Limited | Probiotic Bifidobacterium strain |
EP3589726A1 (en) | 2017-02-28 | 2020-01-08 | Alimentary Health Limited | Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection |
US11813297B2 (en) | 2017-03-23 | 2023-11-14 | Katholieke Universiteit Leuven, Ku Leuven R & D | Probiotic Lactobacillus casei strain and its uses |
US20230106819A1 (en) | 2020-03-13 | 2023-04-06 | Precisionbiotics Group Limited | Bifidobacterium longum |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1514949A (fr) * | 1965-06-01 | 1968-03-01 | Texim Entpr Economique D Etat | Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus |
US3632746A (en) * | 1967-08-30 | 1972-01-04 | Chugai Pharmaceutical Co Ltd | Dried stable anti-tumor preparations and process for preparing the same |
FR2244464A1 (en) * | 1973-06-26 | 1975-04-18 | Serozym Laboratoires | Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc. |
-
1979
- 1979-02-27 JP JP2133979A patent/JPS55113718A/ja active Granted
-
1980
- 1980-02-20 NL NLAANVRAGE8001045,A patent/NL189999C/nl not_active IP Right Cessation
- 1980-02-25 CA CA346,374A patent/CA1124176A/en not_active Expired
- 1980-02-25 CH CH1491/80A patent/CH653556A5/de not_active IP Right Cessation
- 1980-02-26 BR BR8001129A patent/BR8001129A/pt unknown
- 1980-02-26 FR FR8004213A patent/FR2450108B1/fr not_active Expired
- 1980-02-26 US US06/124,725 patent/US4347240A/en not_active Expired - Lifetime
- 1980-02-27 IT IT67302/80A patent/IT1129802B/it active
- 1980-02-27 DE DE19803007412 patent/DE3007412A1/de not_active Ceased
-
1983
- 1983-06-30 SG SG381/83A patent/SG38183G/en unknown
-
1984
- 1984-03-15 HK HK237/84A patent/HK23784A/xx not_active IP Right Cessation
-
1985
- 1985-12-30 MY MY10/85A patent/MY8500010A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BR8001129A (pt) | 1980-11-04 |
JPS55113718A (en) | 1980-09-02 |
NL189999C (nl) | 1993-10-01 |
DE3007412A1 (de) | 1980-11-06 |
FR2450108B1 (fr) | 1988-10-28 |
JPS6234727B2 (nl) | 1987-07-28 |
IT8067302A0 (it) | 1980-02-27 |
CA1124176A (en) | 1982-05-25 |
CH653556A5 (de) | 1986-01-15 |
NL8001045A (nl) | 1980-08-29 |
MY8500010A (en) | 1985-12-31 |
FR2450108A1 (fr) | 1980-09-26 |
HK23784A (en) | 1984-03-23 |
US4347240A (en) | 1982-08-31 |
IT1129802B (it) | 1986-06-11 |
NL189999B (nl) | 1993-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG38183G (en) | Antitumour agent | |
CS216180A2 (en) | Zpusob vyroby oplatek | |
GB2040591B (en) | Rc-networks | |
GB2045410B (en) | Float-drier | |
GB2046928B (en) | Photodrafting | |
ZA801422B (en) | 9-aminoalkylfluorenes | |
JPS55102412A (en) | Selffemulsifying antifrothing agent | |
JPS5651423A (en) | Antiviral agent | |
JPS5695058A (en) | Microosyringe | |
JPS55102410A (en) | Antifrothing agent | |
GB2065962B (en) | Thyratrosns | |
JPS5690262A (en) | Electriccsignal weightinggnetwork | |
JPS5620636A (en) | Held | |
CS149380A2 (en) | Zpusob cisteni merkaptobenzothiazolu | |
GB2058759B (en) | 1-halogen-e-homoeburnanes | |
JPS564700A (en) | Claning agent | |
HK53786A (en) | 17-cycloalkylmethyl-6-methylene-morphinane-derivatives | |
JPS5621872A (en) | Dottmatrixxprinter | |
JPS5629516A (en) | Antiieumycetes agent | |
GB2060461B (en) | Belt-knife splitting-machine | |
JPS5642976A (en) | Groundinggresistance reducing agent | |
GB8303500D0 (en) | Formylpiperidinobutyrophenones | |
JPS5641681A (en) | Groundinggresistance reducing agent | |
CS175679A2 (en) | Vodovaha | |
BG30041A1 (en) | Antitumour means |